Advanced search
Publication Cover
Acta Orthopaedica Volume 81, 2010 - Issue 4
Journal homepage
849
Views
4
CrossRef citations to date
0
Altmetric
Research Article

BMPs in periprosthetic tissues around aseptically loosened total hip implants

Ville Waris Mikkeli Central Hospital, Mikkeli
,
Eero Waris Department of Hand Surgery, Helsinki University Central Hospital, Helsinki
,
Tarvo Sillat Department of Medicine, Institute of Clinical Medicine, Helsinki University Central Hospital, Biomedicum, Helsinki; Department of Anatomy, Institute of Biomedicine, University of Helsinki
&
Yrjö T Konttinen Department of Medicine, Institute of Clinical Medicine, Helsinki University Central Hospital, Biomedicum, Helsinki; ORTON Orthopaedic Hospital of the ORTON Foundation, Helsinki; COXA Hospital for Joint Replacement, Tampere, FinlandCorrespondence[email protected]
Pages 420-426 | Received 17 Aug 2009, Accepted 21 Feb 2010, Published online: 02 Jun 2010

  • Anderson HC, Hodges PT, Aguilera XM, Missana L, Moylan PE. Bone morphogenetic protein (BMP) localization in developing human and rat growth plate, metaphysis, epiphysis, and articular cartilage. J Histochem Cytochem 2000; 48:1493-502.
  • Badlani N, Inoue A, Healey R, Coutts R, Amiel D. The protective effect of OP-1 on articular cartilage in the development of osteoarthritis. Osteoarthritis Cartilage 2008; 16:600-6.
  • Blom AB, van Lent PL, Holthuysen AE, van der Kraan PM, Roth J, van Rooijen N, van den Berg WB. Synovial lining macrophages mediate osteophyte formation during experimental osteoarthritis. Osteoarthritis Cartilage 2004; 12:627-35.
  • Bragdon CR, Doherty AM, Rubash HE, Jasty M, Li XJ, Seeherman H, Harris WH. The efficacy of BMP-2 to induce bone ingrowth in a total hip replacement model. Clin Orthop 2003; (417):50-61.
  • Bramlage CP, Häupl T, Kaps C, Ungethüm U, Krenn V, Pruss A, Müller GA, Strutz F, Burmester GR. Decrease in expression of bone morphogenetic proteins 4 and 5 in synovial tissue of patients with osteoarthritis and rheumatoid arthritis. Arthritis Res Ther 2006; 8:R58.
  • Champagne CM, Takebe J, Offenbacher S, Cooper LF. Macrophage cell lines produce osteoinductive signals that include bone morphogenetic protein-2. Bone 2002; 30:26-31.
  • Csiszar A, Labinskyy N, Jo H, Ballabh P, Ungvari Z. Differential proinflammatory and prooxidant effects of bone morphogenetic protein-4 in coronary and pulmonary arterial endothelial cells. Am J Physiol Heart Circ Physiol 2008; 295:H569-77.
  • Cunningham NS, Paralkar V, Reddi AH. Osteogenin and recombinant bone morphogenetic protein 2B are chemotactic for human monocytes and stimulate transforming growth factor beta 1 mRNA expression. Proc Natl Acad Sci U S A 1992; 89:11740-4.
  • Detmer K, Steele TA, Shoop MA, Dannawi H. Lineage-restricted expression of bone morphogenetic protein genes in human hematopoietic cell lines. Blood Cells Mol Dis 1999; 25:310-23.
  • Govender S, Csimma C, Genant HK, ; BMP-2 Evaluation in Surgery for Tibial Trauma (BESTT) Study Group. Recombinant human bone morphogenetic protein-2 for treatment of open tibial fractures: a prospective, controlled, randomized study of four hundred and fifty patients. J Bone Joint Surg (Am) 2002; 84: 2123-34.
  • Harris WH. Osteolysis and particle disease in hip replacement. A review. Acta Orthop Scand 1994; 65:113-23.
  • Hentunen TA, Lakkakorpi PT, Tuukkanen J, Lehenkari PP, Sampath TK, Väänänen HK. Effects of recombinant human osteogenic protein-1 on the differentiation of osteoclast-like cells and bone resorption. Biochem Biophys Res Commun 1995; 209:433-43.
  • Honsawek S, Chayanupatkul M, Tanavalee A, Sakdinakiattikoon M, Deepaisarnsakul B, Yuktanandana P, Ngarmukos S. Relationship of plasma and synovial fluid BMP-7 with disease severity in knee osteoarthritis patients: a pilot study. Int Orthop 2009; 33:1171-5.
  • Itoh K, Udagawa N, Katagiri T, Iemura S, Ueno N, Yasuda H, Higashio K, Quinn JM, Gillespie MT, Martin TJ, Suda T, Takahashi N. Bone morphogenetic protein 2 stimulates osteoclast differentiation and survival supported by receptor activator of nuclear factor-kappaB ligand. Endocrinology 2001; 142:3656-62.
  • Jones AL, Bucholz RW, Bosse MJ, Mirza SK, Lyon TR, Webb LX, Pollak AN, Golden JD, Valentin-Opran A. BMP-2 Evaluation in Surgery for Tibial Trauma-Allgraft (BESTT-ALL) Study Group. Recombinant human BMP-2 and allograft compared with autogenous bone graft for reconstruction of diaphyseal tibial fractures with cortical defects. A randomised, controlled trial. J Bone Joint Surg (Am) 2006; 88:1431-41.
  • Kloen P, Di Paola M, Borens O, Richmond J, Perino G, Helfet DL, Goumans MJ. BMP signaling components are expressed in human fracture callus. Bone 2003; 33:362-71.
  • Lassus J, Salo J, Jiranek WA, Santavirta S, Nevalainen J, Matucci-Cerinic M, Horák P, Konttinen YT. Macrophage activation results in bone resorption. Clin Orthop 1998; (352):7-15.
  • Lories RJ, Luyten FP. Bone morphogenetic protein signaling in joint homeostasis and disease. Cytokine Growth Factor Rev 2005; 16:287-98.
  • Lories RJ, Derese I, Ceuppens JL, Luyten FP. Bone morphogenetic proteins 2 and 6, expressed in arthritic synovium, are regulated by proinflammatory cytokines and differentially modulate fibroblast-like synoviocyte apoptosis. Arthritis Rheum 2003; 48:2807-18.
  • Ma J, Chen T, Mandelin J, Ceponis A, Miller NE, Hukkanen M, Ma GF, Konttinen YT. Regulation of macrophage activation. Cell Mol Life Sci 2003; 60:2334-46.
  • Mandelin J, Li TF, Liljeström M, Kroon ME, Hanemaaijer R, Santavirta S, Konttinen YT. Imbalance of RANKL/RANK/OPG system in interface tissue in loosening of total hip replacement. J Bone Joint Surg (Br) 2003; 85:1196-201.
  • Meynard D, Kautz L, Darnaud V, Canonne-Hergaux F, Coppin H, Roth MP. Lack of the bone morphogenetic protein BMP6 induces massive iron overload. Nat Genet 2009; 41:478-81.
  • Mishina Y, Starbuck MW, Gentile MA, Fukuda T, Kasparcova V, Seedor JG, Hanks MC, Amling M, Pinero GJ, Harada S, Behringer RR. Bone morphogenetic protein type IA receptor signaling regulates postnatal osteoblast function and bone remodeling. J Biol Chem 2004; 279:27560–6.
  • Murakami N, Saito N, Takahashi J, Ota H, Horiuchi H, Nawata M, Okada T, Nozaki K, Takaoka K. Repair of a proximal femoral bone defect in dogs using a porous surfaced prosthesis in combination with recombinant BMP-2 and a synthetic polymer carrier. Biomaterials 2003; 24:2153-9.
  • Myllymaa S*, Kaivosoja E*, Myllymaa K, Sillat T. Korhonen H, Lappalainen R, Konttinen YT. Adhesion, spreading and osteogenic differentiation of mesenchymal stem cells cultured on micropatterned diamond, titanium, tantalum and chromium coating (*equal contribution). J Mater Sci Mater Med 2010; 21:329-34.
  • Rader ChP, Baumann B, Rolf O, Radke S, Hendrich Ch, Schütze N, Seufert J, Jakob F. Detection of differentially expressed genes in particle disease using array-filter analysis. Biomed Tech (Berl) 2002; 47:111-6.
  • Santavirta S, Konttinen YT, Bergroth V, Eskola A, Tallroth K, Lindholm TS. Aggressive granulomatous lesions associated with hip arthroplasty. Immunopathological studies. J Bone Joint Surg (Am) 1990a; 72:252-8.
  • Santavirta S, Hoikka V, Eskola A, Konttinen YT, Paavilainen T, Tallroth K. Aggressive granulomatous lesions in cementless total hip arthroplasty. J Bone Joint Surg (Br) 1990b; 72:980-4.
  • Santavirta S, Gristina AG, Konttinen YT. Cemented vs cementless hip arthroplasty. A review of prosthetic biocompatibility. Acta Orthop Scand 1992; 63:225-32.
  • Santavirta S, Xu JW, Hietanen J, Ceponis A, Sorsa T, Kontio R, Konttinen YT. Activation of periprosthetic connective tissue in aseptic loosening of total hip replacements. Clin Orthop Rel Res 1998; 352:16-24.
  • Schmalzried TP, Jasty M, Harris WH. Periprosthetic bone loss in total hip arthroplasty. Polyethylene wear debris and the concept of the effective joint space. J Bone Joint Surg (Am) 1992; 74:849-63.
  • Seib FP, Franke M, Jing D, Werner C, Bornhäuser M. Endogenous bone morphogenetic proteins in human bone marrow-derived multipotent mesenchymal stromal cells. Eur J Cell Biol 2009; 88:257-71.
  • Willert HG, Semlitsch M. Reactions of the articular capsule to wear products of artificial joint prostheses. J Biomed Mater Res 1977; 11:157-64.
  • Wutzl A, Brozek W, Lernbass I, Rauner M, Hofbauer G, Schopper C, Watzinger F, Peterlik M, Pietschmann P. Bone morphogenetic proteins 5 and 6 stimulate osteoclast generation. J Biomed Mater Res A 2006; 77:75–83.
  • Zeisberg M, Hanai J, Sugimoto H, Mammoto T, Charytan D, Strutz F, Kalluri R. BMP-7 counteracts TGF-beta1-induced epithelial-to-mesenchymal transition and reverses chronic renal injury. Nat Med 2003; 9:964-8.
  • Zoricic S, Maric I, Bobinac D, Vukicevic S. Expression of bone morphogenetic proteins and cartilage-derived morphogenetic proteins during osteophyte formation in humans. J Anat 2003; 202:269-77.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.